MedTrace Logo

a Randomized Controlled Trial of the Intake of Organic and Inorganic Phosphate in Peritoneal Dialysis Patients

NCT04600193 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2021-03-18

No results posted yet for this study

Summary

Hyperphosphatemia is a common problem among patientens suffering from chronic kidney disease. Hyperphosphatemia is associated with increased risk of cardiovascular diseases. One of the treatments are through the diet, where patients are instructed ind reducing their daily intake of phosphate. But since phosphate exists in both organic and inorganic forms in the diet, this leads to several problems. Informations of the bioavability and furthermore the effect of plasma koncentrations of phosphate are lacking for both forms of phosphate.

Conditions

  • Chronic Kidney Disease Requiring Chronic Dialysis

Interventions

OTHER

Diet containing organic phosphate

The patients will be receiving a 5 days diet containing organic phosphate

OTHER

Diet containing inorganic phosphate

The patients will be receiving a 5 days diet containing inorganic phosphate

Sponsors & Collaborators

  • Stine Kristensen

    collaborator UNKNOWN

  • Gita Krüger Mørch

    collaborator UNKNOWN

  • Rizwan Butt

    collaborator UNKNOWN

  • Ditte Hansen

    collaborator UNKNOWN

  • University of Copenhagen

    lead OTHER

Principal Investigators

  • Jens Rikardt Andersen, MD · University of Copenhagen

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-17
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04600193 on ClinicalTrials.gov